Healthcare -
Biotechnology - NASDAQ - US
$ 0.53
-3.46 %
$ 2.51 M
Market Cap
-0.11
P/E
PCSA - CHANGE IN WORKING CAPITAL
Change in Working Capital PCSA - Processa Pharmaceuticals, Inc.
605 K
LAST VALUE
58.54%
2 YEAR CAGR
26.25%
5 YEAR CAGR
23.10%
10 YEAR CAGR